Vivani Medical, Inc. (VANI)
NASDAQ: VANI · Real-Time Price · USD
1.050
+0.020 (1.94%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Vivani Medical Employees
Vivani Medical had 37 employees as of December 31, 2024. The number of employees decreased by 7 or -15.91% compared to the previous year.
Employees
37
Change (1Y)
-7
Growth (1Y)
-15.91%
Revenue / Employee
n/a
Profits / Employee
-$634,757
Market Cap
62.21M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 37 | -7 | -15.91% |
| Dec 31, 2023 | 44 | -6 | -12.00% |
| Dec 31, 2022 | 50 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VANI News
- 11 days ago - Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity - GlobeNewsWire
- 26 days ago - Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 4 weeks ago - Vivani Medical Announces $8.25M Private Placement Equity Financing - GlobeNewsWire
- 4 weeks ago - Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing - GlobeNewsWire
- 4 weeks ago - Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025 - Business Wire
- 6 weeks ago - Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults - Business Wire
- 6 weeks ago - Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business - Business Wire
- 6 weeks ago - EXCLUSIVE: Vivani Medical To Spin Off Cortigent Neurostimulation Business To Create Better Focus On Individual Entities And Shareholder Value - Benzinga